Advertisement

Topics

PARI Respiratory Equipment, Inc. Company Profile

11:15 EDT 26th September 2018 | BioPortfolio

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.


News Articles [450 Associated News Articles listed on BioPortfolio]

Middle East respiratory syndrome

Middle East respiratory syndrome (MERS) is an acute viral respiratory tract infection caused by the novel betacoronavirus. Cases have been limited to the Arabian Peninsula and its surrounding countr...

Green space near home during childhood linked to fewer respiratory problems in adulthood

(European Lung Foundation) Children who have access to green spaces close to their homes have fewer respiratory problems, such as asthma and wheezing, in adulthood, according to new research presented...

The Human Respiratory Microbiome: Implications and Impact

A better understanding of the respiratory microbiome and its impact on lung diseases could have important therapeutic implications. Seminars in Respiratory and Critical Care Medicine

DRE to Attend Major International Medical Equipment Expo in Mexico City

Visit DRE representatives at ExpoMED 2018 to see the company’s latest operating theater equipment selection. LOUISVILLE, Ky. (PRWEB) June 06, 2018 DRE Medical — a leading provider of new and refu...

Respiratory Distress in Pediatric Patients

Respiratory diseases are common in pediatrics, and providers need to have an in-depth knowledge of the presentation, diagnostic approach, and therapeutic options to optimize outcomes.

Are antibiotics overused in treatment of outpatient acute respiratory infections?

(JAMA Network) Antibiotics are most commonly prescribed for acute respiratory infections, although most of these infections are caused by viruses for which antibiotics aren't effective. A new study fo...

Our 40-year heritage is just the beginning of our story in respiratory science. Hear from colleagues in our Respiratory team who contribute every day to transform the treatment of respiratory disease: http://bit.ly/2xa9bFF . #ERSCongress

Our 40-year heritage is just the beginning of our story in respiratory science. Hear from colleagues in our Respiratory team who contribute every day to transform the treatment of respiratory disease:...

Therapeutic Antibodies Show Variations

Differences in production methods for therapeutic antibodies can lead to variations in their structure, depending on the recombinant procedure selected. The distinctions, which are based on a number o...

PubMed Articles [1412 Associated PubMed Articles listed on BioPortfolio]

Respiratory alterations in workers: study of single ports.

To identify alterations in the respiratory system in port workers through radiographic and pulmonary function tests; to identify the use of personal protective equipment during port activities; and to...

Does the Size of a Company Make a Difference in the Prevalence of Exposure to Asthmagens and in the Use of Respiratory Protective Equipment?

About half of all workers in high-income countries work in small companies. However, regulatory bodies and researchers predominantly work with large companies because they are more convenient to study...

Delivering Chest Compressions and Ventilations With and Without Men's Lacrosse Equipment.

  Current management recommendations for equipment-laden athletes in sudden cardiac arrest regarding whether to remove protective sports equipment before delivering cardiopulmonary resuscitation are...

CLEAR: A Novel Approach to Ultrasound Equipment Homeostasis.

Protocols for the sanitation and maintenance of point-of-care ultrasound (US) equipment are lacking. This study introduces the CLEAR protocol (clean, locate, energize, augment supplies, and remove pat...

Nickel release from surgical instruments and operating room equipment.

Background There has been no systematic study assessing nickel release from surgical instruments and equipment used within the operating suite. This equipment represents important potential sources of...

Clinical Trials [2438 Associated Clinical Trials listed on BioPortfolio]

Construction of the Training Mode Adjustable Equipment Sitting Volleyball

The individual adapted sport modalities concentrate most of the technological development for equipment and auxiliary devices, the collective modalities need implements that aid in the dev...

Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study

This study assesses the aerosol delivery characteristics (measured by nebulization time, serum and sputum tobramycin pharmacokinetic parameters) and safety of tobramycin administered for i...

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi

The study should create data for the selection of a clinically relevant primary endpoint to assess the efficacy and safety of Buparid/PARI SINUS as compared to Budes Nasal Spray in the the...

Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study

This study assesses the aerosol delivery characteristics (measured by in vivo lung deposition, nebulization time, serum tobramycin concentrations, and pharmacokinetic parameters) and safet...

Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers

This study will evaluate systemic and urine pharmacokinetics in spontaneously breathing healthy volunteers following a single dose of amikacin/fosfomycin, using the PARI Investigational eF...

Companies [1179 Associated Companies listed on BioPortfolio]

PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is t...

PARI Pharma

PARI Pharma focuses on the development of aerosol delivery devices and comprehensive inhalation drug development to advance aerosol therapies where drug and device can be optimized together. Based on ...

Respiratory Therapeutics Group

RTG is a global manufacturer of Respiratory Devices, with an extensive brand portfolio of respiratory disposable devices, products and service solutions designed by Respira...

Sperian Respiratory Protection USA, LLC

With nearly 6,000 employees worldwide, Sperian Protection (formerly Bacou-Dalloz) is the world's leading manufacturer of personal protective equipment. Sperian's expertise focuses on head, body and fa...

Pulmatrix, Inc.

Pulmatrix, Inc., is a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory ...

More Information about "PARI Respiratory Equipment, Inc." on BioPortfolio

We have published hundreds of PARI Respiratory Equipment, Inc. news stories on BioPortfolio along with dozens of PARI Respiratory Equipment, Inc. Clinical Trials and PubMed Articles about PARI Respiratory Equipment, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PARI Respiratory Equipment, Inc. Companies in our database. You can also find out about relevant PARI Respiratory Equipment, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Asthma
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record